HealthEquity Price to Book Ratio 2014-2024 | HQY
Historical price to book ratio values for HealthEquity (HQY) over the last 10 years. The current price to book ratio for HealthEquity as of November 05, 2024 is 3.61.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| HealthEquity Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-11-05 | 89.23 | 3.61 | |
| 2024-07-31 | 78.48 | $24.70 | 3.18 |
| 2024-04-30 | 78.91 | $24.11 | 3.27 |
| 2024-01-31 | 75.58 | $23.63 | 3.20 |
| 2023-10-31 | 71.68 | $23.17 | 3.09 |
| 2023-07-31 | 67.94 | $22.77 | 2.98 |
| 2023-04-30 | 53.45 | $22.45 | 2.38 |
| 2023-01-31 | 60.85 | $22.37 | 2.72 |
| 2022-10-31 | 77.91 | $22.25 | 3.50 |
| 2022-07-31 | 58.17 | $22.06 | 2.64 |
| 2022-04-30 | 62.32 | $21.99 | 2.83 |
| 2022-01-31 | 53.44 | $22.11 | 2.42 |
| 2021-10-31 | 66.18 | $22.39 | 2.96 |
| 2021-07-31 | 73.98 | $22.28 | 3.32 |
| 2021-04-30 | 75.97 | $22.17 | 3.43 |
| 2021-01-31 | 83.55 | $17.87 | 4.68 |
| 2020-10-31 | 51.49 | $17.61 | 2.92 |
| 2020-07-31 | 51.56 | $17.44 | 2.96 |
| 2020-04-30 | 56.27 | $14.58 | 3.86 |
| 2020-01-31 | 66.06 | $14.50 | 4.56 |
| 2019-10-31 | 56.79 | $14.37 | 3.95 |
| 2019-07-31 | 81.98 | $14.40 | 5.69 |
| 2019-04-30 | 67.75 | $8.44 | 8.03 |
| 2019-01-31 | 62.34 | $7.64 | 8.16 |
| 2018-10-31 | 91.80 | $7.32 | 12.54 |
| 2018-07-31 | 75.50 | $6.95 | 10.86 |
| 2018-04-30 | 65.67 | $6.42 | 10.22 |
| 2018-01-31 | 50.62 | $5.69 | 8.89 |
| 2017-10-31 | 50.22 | $5.51 | 9.11 |
| 2017-07-31 | 45.87 | $5.23 | 8.77 |
| 2017-04-30 | 45.52 | $4.86 | 9.38 |
| 2017-01-31 | 46.25 | $4.40 | 10.51 |
| 2016-10-31 | 33.23 | $4.26 | 7.80 |
| 2016-07-31 | 29.52 | $4.09 | 7.21 |
| 2016-04-30 | 25.15 | $3.84 | 6.54 |
| 2016-01-31 | 21.55 | $3.52 | 6.11 |
| 2015-10-31 | 32.71 | $3.47 | 9.43 |
| 2015-07-31 | 33.66 | $3.34 | 10.07 |
| 2015-04-30 | 26.21 | $2.79 | 9.38 |
| 2015-01-31 | 20.77 | $2.63 | 7.90 |
| 2014-10-31 | 20.40 | $2.57 | 7.95 |
| 2014-07-31 | 17.60 | $0.91 | 19.34 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $7.792B | $1.000B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $96.890B | 12.02 |
| Cencora (COR) | United States | $46.107B | 17.62 |
| DiDi Global (DIDIY) | China | $23.233B | 0.00 |
| ICON (ICLR) | Ireland | $18.679B | 16.64 |
| Revvity (RVTY) | United States | $15.535B | 26.63 |
| Avantor (AVTR) | United States | $15.498B | 23.24 |
| Natera (NTRA) | United States | $15.385B | 0.00 |
| Viatris (VTRS) | United States | $13.858B | 4.22 |
| BioMerieux (BMXMF) | France | $13.601B | 0.00 |
| Solventum (SOLV) | United States | $12.636B | 0.00 |
| CochLear (CHEOY) | Australia | $12.565B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.202B | 28.74 |
| Charles River Laboratories (CRL) | United States | $9.742B | 18.41 |
| Sonic Healthcare (SKHHY) | Australia | $8.273B | 0.00 |
| Doximity (DOCS) | United States | $7.787B | 49.34 |
| Bausch + Lomb (BLCO) | Canada | $6.975B | 32.47 |
| Life Times (LTH) | United States | $4.762B | 31.52 |
| PACS (PACS) | United States | $4.502B | 0.00 |
| Sotera Health (SHC) | United States | $4.367B | 23.36 |
| Organon (OGN) | United States | $4.239B | 4.28 |
| Surgery Partners (SGRY) | United States | $3.778B | 41.86 |
| BrightSpring Health Services (BTSG) | United States | $3.070B | 65.30 |
| Ardent Health Partners (ARDT) | United States | $2.577B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.546B | 0.00 |
| Concentras Parent (CON) | United States | $2.480B | 0.00 |
| Premier (PINC) | United States | $2.271B | 11.34 |
| GoodRx Holdings (GDRX) | United States | $2.254B | 84.86 |
| GeneDx Holdings (WGS) | United States | $2.057B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.575B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.507B | 7.57 |
| Progyny (PGNY) | United States | $1.425B | 25.06 |
| Establishment Labs Holdings (ESTA) | $1.338B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.319B | 12.91 |
| CareDx (CDNA) | United States | $1.228B | 0.00 |
| Agilon Health (AGL) | United States | $1.123B | 0.00 |
| Embecta (EMBC) | United States | $0.864B | 5.76 |
| InnovAge Holding (INNV) | United States | $0.822B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| SBC Medicals (SBC) | United States | $0.722B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.488B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.483B | 0.00 |
| Enhabit (EHAB) | United States | $0.382B | 33.04 |
| DocGo (DCGO) | United States | $0.355B | 13.35 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.309B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.255B | 0.00 |
| ModivCare (MODV) | United States | $0.232B | 7.37 |
| Beauty Health (SKIN) | United States | $0.211B | 0.00 |
| Biodesix (BDSX) | United States | $0.195B | 0.00 |
| LifeMD (LFMD) | United States | $0.192B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.178B | 0.00 |
| MultiPlan (MPLN) | United States | $0.136B | 0.00 |
| Nutex Health (NUTX) | United States | $0.127B | 0.00 |
| So-Young (SY) | China | $0.092B | 22.35 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.059B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| OncoCyte (OCX) | United States | $0.049B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.63 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.036B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| Oncology Institute (TOI) | United States | $0.021B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |